High efficiency targeted in situ genome-wide profiling
AssigneeFred Hutchinson Cancer Center
InventorsSteven Henikoff, Hatice Seda Kaya Okur, Terri Dawn Bryson, Peter James Skene
Life of this patent
Estimating the term…
Loading patent…
AssigneeFred Hutchinson Cancer Center
InventorsSteven Henikoff, Hatice Seda Kaya Okur, Terri Dawn Bryson, Peter James Skene
Estimating the term…
A method for detecting the binding of a chromatin-associated factor of interest to a sequence of chromatin DNA in a cell, including: contacting a permeabilized cell or nucleus with a specific binding agent that specifically recognizes the chromatin-associated factor of interest, wherein the specific binding agent is linked to a nuclease that is inactive or an activatable transposome; activating the nuclease or transposase, thereby excising the sequence of chromatin DNA bound to the chromatin-associated factor of interest; isolating the excised DNA; and determining the sequence of the excised DNA, thereby detecting binding of a chromatin-associated factor of interest to a sequence of chromatin DNA in the cell.
A method for detecting the binding of a chromatin-associated factor of interest to a sequence of chromatin DNA in a cell or nucleus, comprising:
A method for detecting the binding of a chromatin-associated factor of interest to a sequence of chromatin DNA in a cell or nucleus, comprising:
Dependencies are inferred from the claim text.